Skip to main content
. Author manuscript; available in PMC: 2021 Nov 11.
Published in final edited form as: Environ Mol Mutagen. 2020 Jul 27;61(8):807–819. doi: 10.1002/em.22393

TABLE 1.

Subject information

Source Total no. subjects (males/females) Age: Range (yr) Age: Mean ± SD (yr) Medical condition
Commercial supplier (Biological Specialty Company) 300 (150/150) 19–73 38.2 ± 12.1 Self-reported healthy adults
URMC, Department of radiation oncology 7 (2/5) 24–57 42.1 ± 11.2 Self-reported healthy adults
Texas Children’s hospital, Department of pediatrics 26 (10/16) 0 (cord blood) – 1.2 0.2 ± 0.3 Healthy (cord bloods) or infants with congenital heart defect
URMC, Department of pediatrics 30 (11/19) 8–17 14.3 ± 3.0 Constipation or irritable bowel syndrome; otherwise healthy